LOGOLOGOLOGOLOGO
    • About us
      • What we do
      • Who we are
        • Governance
        • Staff
        • Vacancies
    • Members
      • EuropaBio Members
      • About Membership
    • How we work
      • Healthcare Biotechnology Council
        • Patient BioForum
        • Study – Impact of the EU’s General Pharmaceutical Legislation
      • Industrial Biotechnology Council
        • EFIB
        • Microorganisms
      • National Associations Council
      • SME Platform
      • Biomanufacturing Platform
        • Biotechnology in our Lives
    • Activities
      • 25 Years of Innovation
      • The EU Biotech Act
      • European Biotech Week
      • EU Projects
        • PRIMED Project
        • APROVALS Project
    • News & Events
      • News
      • Events
    • Library
    Become a member
    ✕

    Health and Life Sciences Cluster Bulgaria joins EuropaBio: AI as enabler of biotech growth

    21/04/2021
    PRESS RELEASE

    Health and Life Sciences Cluster Bulgaria joins EuropaBio

    Brussels, 21 April 2021 – EuropaBio is pleased to announce that the Health and Life Sciences Cluster Bulgaria has joined as a National Association.

    The Cluster represents a growing biotechnology community within Bulgaria, across all sectors and reflects a growing national competence in AI, with the ’AI Cluster Bulgaria’, part of a borderless AI Initiative with Austria, Sweden, Serbia and the UK.

    In joining EuropaBio and becoming part of the National Associations Council, the Cluster aims to help lead initiatives for AI in biotechnology as well as benefitting from the EuropaBio community to help build Bulgaria’s first Bioethical Hub for translational medicine.

    EuropaBio Director-General Dr. Claire Skentelbery commented “It is excellent for EuropaBio to learn from, and support, countries such as Bulgaria in the development of their biotechnology industries. We are very much looking forward to their active participation across all our activities.”

    Kristina Eskenazi, Chair of the Managing Board, added “Bulgaria has strongly growing economic activity from biotechnology, and our focus on technologies such as AI allows us to grow the skills and international partnerships needed to lead Europe in enabling biotech growth.”

    Download the full PRESS RELEASE below.

    Health and Life Sciences Cluster Bulgaria joins EuropaBio


    Download
    Health-Life-Sciences-Cluster-Bulgaria-Press-Release-1Download

    Share
    Communications Team
    Communications Team

    Related posts

    13/02/2026

    The Association of Biopharmaceutical Manufacturers in Latvia (BRAL) joins EuropaBio: Promoting Access to Innovative Therapies


    Read more
    11/02/2026

    Call for tender: EU Biotech and Life Sciences Alliance MEP Group Secretariat services 2026


    Read more
    06/02/2026

    OECD: A comparison of the innovation and regulatory environments for biotechnology and biosolutions across the European Union and the United States


    Read more

    Important links

    • The Association of Biopharmaceutical Manufacturers in Latvia (BRAL) joins EuropaBio: Promoting Access to Innovative Therapies
    • Call for tender: EU Biotech and Life Sciences Alliance MEP Group Secretariat services 2026

    Categories in our Newsroom

    EBIO-white

    EuropaBio represents corporate and associate members across sectors, plus national and regional biotechnology associations which, in turn, represent over 5000 biotech companies, 4600 out of them are SMEs.

    Contact us

    Extra links

    Members
    Staff
    Privacy policy
    Legal & cookies
    Events
    Newsroom

    Become a member

    Media pack

    © 2026 Europabio. All Rights Reserved. Designed by EYAS
    Become a member

    Vitamin B2

    The biomanufacturing of Vitamin B2 led to the reduction of 75% of fossil raw materials and 50% operating costs, compared to the chemical process. Vitamin B2 is used in the food, feed or healthcare sectors.

    Insulin

    Insulin is one of the most widely known biopharmaceutical. Biotechnology revolutionised its manufacturing process and led to the development of new types of insulin through r-DNA technology.

    Detergents

    Enzymes and biosurfactancts are alternative ingredients that improve the performance of detergents, while leading to water and energy savings and reductions in CO2 emissions and water toxicity.

    Clothes

    Clothes made from alternative fibres produced by microorganisms can be 8x stronger than steel, 100% recyclable, biodegradable and replace fossil-fuel based or resource-intensive textiles.

    Algal Omega 3

    Algal Omega-3 is an innovative feed product for aquaculture. It reduces the impact on climate change by 30-40% compared to fish oil and saves 60 tons of wild fish for every ton of Algal Omega-3 used.

    Cheese

    Cheese is a vegetarian product thanks to biotechnology. Biotechnology is also essential to produce lactose- or cholesterol-free cheese, as well as alternative proteins.